TY - JOUR T1 - Noninvasive methods to assess liver disease in patients with hepatitis B or C JF - Gastroenterology Y1 - 2012 A1 - Castera, L. KW - analysis KW - Antiviral Agents KW - Area Under Curve KW - Biological Markers KW - Biopsy KW - blood KW - complications KW - diagnosis KW - Disease KW - Disease Progression KW - drug therapy KW - Elasticity KW - Elasticity Imaging Techniques KW - Fibrosis KW - France KW - hepatitis KW - Hepatitis B KW - Hepatitis B,Chronic KW - Hepatitis C KW - Hepatitis C,Chronic KW - Humans KW - Infection KW - Liver KW - Liver Cirrhosis KW - methods KW - Paris KW - pathology KW - Patients KW - Predictive Value of Tests KW - prevention & control KW - Prognosis KW - Reproducibility of Results KW - Risk KW - Roc Curve KW - Sensitivity and Specificity KW - Serum KW - Severity of Illness Index KW - therapeutic use KW - virology VL - 142 SP - 1293-1302 IS - 6 ER -